Aurobindo Pharma arm enters pact to form JV in China with Luoxin

"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharma said in a filing to BSE.

Original source: https://health.economictimes.indiatimes.com/news/pharma/aurobindo-pharma-arm-enters-pact-to-form-jv-in-china-with-luoxin/67044369?utm_source=RSS&utm_medium=ETRSS

Related Posts